MedTest Dx FDA-approved quantitative test for G6PD
May 2020—MedTest Dx announced the availability of its Pointe Scientific–branded assay for the highly sensitive quantification of G6PD in whole blood.
Webinars and Sponsored Roundtables — Register Now
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, July 15, 2026, 1:00-2:00 PM ET
Hear an expert discuss how to integrate Kappa and Lambda in situ hybridization testing into your standard hematopathology workflow to accurately assess B-cell and plasma cell clonality. You will also gain the skills to recognize testing pitfalls in challenging reactive versus neoplastic proliferations and apply ancillary tools to resolve complex cases.
Webinar presenter Xiaojun Wu, MD, PhD, Assistant professor, Director of Hematopathology Section at NCR of Johns Hopkins Medicine Department of Pathology, SOM at Johns Hopkins University
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
MedTest Dx
MedTest Dx FDA-approved quantitative test for G6PD
April 20, 2020—MedTest Dx announced the availability of its Pointe Scientific–branded assay for the highly sensitive quantification of G6PD in whole blood.
MedTest Dx releases new line of calibrators, controls
September 2019—MedTest Dx introduced at the 2019 American Association for Clinical Chemistry annual scientific meeting an improved line of Clinitox Calibrators and Controls for confirmation testing. The product line aims to provide laboratories performing drugs of abuse testing a comprehensive and reliable calibration and controls solution with extended shelf life and simplified documentation.
MedTest chem assays, hematology analyzer
Aug. 2, 2018—MedTest Dx introduced its BA-800M Clinical Analyzer for general chemistry with a full line of reagents and launched its BC-5390 5-Part Differential Hematology Analyzer at the 2018 American Association for Clinical Chemistry Annual Scientific Meeting, in Chicago. The MedTest Dx BA-800M is a fully automated, discrete random-access chemistry analyzer designed for mid- to large-volume clinical testing laboratories now available with reagents manufactured in the U.S. in a GMP-regulated and ISO 13485-certified environment. The BA-800M has a throughput of
Urine drug tests for forensic use, 2/18
February 2018—MedTest announced the commercial availability of four forensic use only urine drug tests for use on its BS-200, BS-480, and BA-800M chemistry analyzers. The four new assays are DRI Fentanyl, Cedia AB-PINACA (spice K2), Cedia UR-144/XLR-11 (spice K2), and DRI Ethyl Glucuronide.
Full chemistry menu for BioLis 24i instrument, 9/17
September 2017—MedTest’s Pointe Scientific product brand has developed a full line of chemistry reagents that are manufactured and packaged in barcoded reagent containers for use on the BioLis 24i chemistry analyzer, also known as the CLC480 or MGC 240 chemistry analyzer.
Drugs of abuse screening reagents, 6/17
June 2017—MedTest announced the commercial launch of urine drugs of abuse screening reagents on the Mindray BA-800M chemistry analyzer for use in clinical laboratories in the United States.
Drugs of abuse screening reagents, 4/17
April 2017—MedTest announced the commercial launch of urine drugs of abuse screening reagents on the Mindray BA-800M chemistry analyzer for use in clinical laboratories in the United States.
Hematology analyzer cleared, 11/16
November 2016—Mindray has received 510(k) clearance from the Food and Drug Administration to market and sell the Mindray BC-5390 Auto Hematology Analyzer. The Mindray BC-5390 analyzer is designed to meet the testing needs of mid-volume hematology laboratories while offering features commonly found on large-volume analyzers.
25-OH vitamin D assay, 6/16
June 2016—MedTest announced the availability of a 25-OH Vitamin D Assay for the BS-480 chemistry analyzer. MedTest is the exclusive U.S. distributor of the BS-480 analyzer including manufacturing and distribution of reagents, calibrators, and quality control products for the general chemistry and drugs of abuse testing markets in the United States and Canada.